Tirzep Injection 15 mg/0.5 ml contains Tirzepatide, a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist designed for the treatment of type 2 diabetes mellitus (T2DM) in adults. By targeting both GIP and GLP-1 pathways, Tirzepatide enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite. This higher dose is intended for patients requiring advanced glycemic control after titration from lower doses.

Tirzepatide also provides benefits in weight management, making it a versatile therapy for comprehensive diabetes care.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Tirzep Injection is indicated for:

• Adults with type 2 diabetes mellitus requiring additional glycemic control
• Adjunct therapy for patients not adequately controlled with diet and exercise
• Combination therapy with oral antihyperglycemic agents if required
• Patients seeking metabolic benefits including weight reduction

Mechanism of Action

Tirzepatide exerts its effects through dual receptor agonism:

• GIP receptor activation: Enhances glucose-dependent insulin secretion, improving postprandial glucose control.
• GLP-1 receptor activation: Suppresses glucagon release, slows gastric emptying, and reduces appetite.

These combined actions improve fasting and postprandial blood glucose levels, lower HbA1c, and support weight management.

Dosage and Administration

• Administered subcutaneously once weekly.
• Dose escalation: Start at 2.5 mg, then 5 mg, 7.5 mg, and finally 15 mg as guided by a healthcare provider.
• Inject into the abdomen, thigh, or upper arm; rotate injection sites to reduce irritation.
• Do not mix with other injectable medications.
• Strict adherence to the prescribed schedule is essential for optimal glycemic control.

Benefits

• Significant reduction in HbA1c for type 2 diabetes
• Supports weight management as part of a comprehensive treatment plan
• Convenient once-weekly dosing improves patient adherence
• Reduces fasting and postprandial glucose levels
• Dual GIP/GLP-1 action provides superior metabolic control compared to single-agent therapy

Side Effects

Common side effects:

• Nausea, vomiting, or diarrhea
• Constipation
• Injection site reactions (redness, swelling, itching)
• Decreased appetite
• Headache or fatigue

Serious but rare side effects:

• Hypoglycemia, particularly with insulin or sulfonylurea use
• Pancreatitis (persistent severe abdominal pain)
• Allergic reactions, including anaphylaxis
• Thyroid C-cell tumors (rare; contraindicated in patients with a personal or family history of medullary thyroid carcinoma)

Seek medical attention immediately if severe symptoms or allergic reactions occur.

Precautions and Warnings

• Not for type 1 diabetes or diabetic ketoacidosis.
• Monitor for pancreatitis in patients with a history of gastrointestinal disorders.
• Pregnancy and breastfeeding should only use under medical supervision.
• Regular blood glucose monitoring is essential, especially when combined with other antidiabetic drugs.
• Use with caution in patients with severe renal or hepatic impairment.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Drug Interactions

Tirzep Injection may interact with:

• Other antidiabetic medications (risk of hypoglycemia)
• Oral drugs with narrow therapeutic indices (due to delayed gastric emptying)
• Medications affecting gastrointestinal motility

Always inform your healthcare provider about all medications and supplements being taken.

Storage

• Store in a refrigerator at 2–8°C; do not freeze
• Protect from light and heat
• Keep out of reach of children
• Do not use after the expiration date
• Follow package instructions for usage period after opening.